Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2026-03-01 @ 6:02 AM
Study NCT ID:
NCT06505369
Status:
RECRUITING
Last Update Posted:
2024-07-17
First Post:
2024-06-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients
Sponsor:
North Estonia Medical Centre
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CT number 2023-508212-38-00
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |